4//SEC Filing
Cline Darren S 4
Accession 0001209191-23-024348
CIK 0001445499other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:58 PM ET
Size
5.6 KB
Accession
0001209191-23-024348
Insider Transaction Report
Form 4
Cline Darren S
Director
Transactions
- Award
Stock Option (right to buy)
2023-04-12+20,013→ 20,013 totalExercise: $1.42Exp: 2033-04-11→ Common Stock (20,013 underlying)
Footnotes (1)
- [F1]The option vests as to 1/3rd of the total shares on April 12, 2024 and then 1/36th of the total shares vests on each monthly anniversary thereafter, with 100% of the total shares vested and exercisable on April 12, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
IMPEL PHARMACEUTICALS INC
CIK 0001445499
Entity typeother
Related Parties
1- filerCIK 0001633639
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 4:58 PM ET
- Size
- 5.6 KB